Amylin Pharmaceuticals to Present at Cowen and Company Annual Health Care Conference
March 10 2009 - 4:15PM
PR Newswire (US)
SAN DIEGO, March 10 /PRNewswire-FirstCall/ -- Amylin
Pharmaceuticals, Inc. (NASDAQ:AMLN) will be presenting at the Cowen
and Company 29th Annual Health Care Conference on Tuesday, March
17, 2009 at 8:00 a.m. PT / 11:00 a.m. ET in Boston. Daniel M.
Bradbury, president and chief executive officer of Amylin
Pharmaceuticals, will be providing a corporate overview. The live
presentation and breakout session will be webcast, and a recording
will be made available following the event. The webcast and
recording will be accessible through Amylin's corporate Web site,
located at http://www.amylin.com/. To access the live webcast,
please log on to Amylin's site approximately fifteen minutes prior
to the presentation to register and download any necessary audio
software. About Amylin Pharmaceuticals Amylin Pharmaceuticals is a
biopharmaceutical company committed to improving lives through the
discovery, development and commercialization of innovative
medicines. Amylin has developed and gained approval for two
first-in-class medicines for diabetes, SYMLIN(R) (pramlintide
acetate) injection and BYETTA(R) (exenatide) injection. Amylin's
research and development activities leverage the Company's
expertise in metabolism to develop potential therapies to treat
diabetes and obesity. Amylin is headquartered in San Diego,
California. Further information about Amylin Pharmaceuticals is
available at http://www.amylin.com/. DATASOURCE: Amylin
Pharmaceuticals, Inc. CONTACT: Michael York, Senior Director,
Investor Relations of Amylin Pharmaceuticals, Inc.,
+1-858-552-2200, ext. 8602 Web Site: http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024